Difference between revisions of "Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5 (Q9628)"
Jump to navigation
Jump to search
(Added link to [sliswiki]: Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5, #quickstatements; #temporary_batch_1589988087154) |
(Created claim: Page(s) (P105): 91-98, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / First Author string | |||||||||||||||
| + | Zaidi AH | ||||||||||||||
| Property / First Author string: Zaidi AH / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1097/SLA.0000000000001908 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 27471841 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2017
| ||||||||||||||
| Property / Publication Date: 2017 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Ann. Surg. | ||||||||||||||
| Property / Published In Name String: Ann. Surg. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 266 | ||||||||||||||
| Property / Volume: 266 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English) | ||||||||||||||
| Property / title: PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 91-98 | ||||||||||||||
| Property / Page(s): 91-98 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:39, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Zaidi AH, et al. Ann. Surg. (2017) cited as Ref 365 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Zaidi AH
0 references
2017
0 references
Ann. Surg.
0 references
266
0 references
PI3K/mTOR dual inhibitor LY3023414 demonstrates potent antitumor efficacy against esophageal adenocarcinoma in a rat model (English)
0 references
91-98
0 references
